United Therapeutics (UTHR) legal chief sells 8,300 shares
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp (UTHR) reported that EVP & General Counsel Paul A. Mahon exercised stock options for 8,300 shares of common stock at an exercise price of $146.03 per share on August 20, 2026, and sold 8,300 shares in multiple open-market trades at prices between approximately $520.03 and $527.21. The options exercise and resulting share sales were carried out under a pre-arranged Rule 10b5-1 plan entered into on August 11, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 8,300 shares ($3.13M approx. pre-tax spread)
Exercise and Sale
13 txns
Insider
MAHON PAUL A
Role
EVP & GENERAL COUNSEL
Sold
8,300 shs ($4.34M)
Approx. gross sale proceeds
$4.34M
Approx. exercise cost
$1.21M
Approx. pre-tax spread
$3.13M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1 | 2,690 | $0.00 | $0.00 |
| Exercise | Stock Option F1 | 5,610 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 2,690 | $146.03 | $393K |
| Exercise | Common Stock F1 | 5,610 | $146.03 | $819K |
| Sale | Common Stock F1 | 2,690 | $524.15 | $1.41M |
| Sale | Common Stock F1, F2 | 502 | $520.0331 | $261K |
| Sale | Common Stock F1, F3 | 1,819 | $521.0406 | $948K |
| Sale | Common Stock F1, F4 | 787 | $522.0036 | $411K |
| Sale | Common Stock F1, F5 | 850 | $522.7838 | $444K |
| Sale | Common Stock F1, F6 | 192 | $523.6897 | $101K |
| Sale | Common Stock F1, F7 | 940 | $525.2504 | $494K |
| Sale | Common Stock F1, F8 | 400 | $526.385 | $211K |
| Sale | Common Stock F1 | 120 | $527.21 | $63K |
Holdings After Transaction:
Stock Option — 64,140 shares (Direct);
Common Stock — 45,172 shares (Direct)
Footnotes (8)
- F1. This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $519.33 to $520.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $520.36 to $521.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $521.39 to $522.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $522.43 to $523.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $523.45 to $523.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $524.57 to $525.435. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $526.145 to $526.625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Options exercised: 8,300 shares
Exercise price: $146.03 per share
Shares sold: 8,300 shares
+3 more
6 metrics
Options exercised
8,300 shares
Stock options exercised by Paul A. Mahon on 2026-08-20
Exercise price
$146.03 per share
Conversion or exercise price of stock options exercised on 2026-08-20
Shares sold
8,300 shares
Total UTHR common shares sold in reported transactions on 2026-08-20
Lowest sale price range
$519.33 to $520.25 per share
Price range for one set of trades, with weighted average used in the report
Highest sale price range
$526.145 to $526.625 per share
Price range for another set of trades, with weighted average used in the report
10b5-1 plan adoption date
August 11, 2025
Date Paul A. Mahon entered into the pre-arranged Rule 10b5-1 plan
Key Terms
Rule 10b5-1 plan, weighted average price, stock options, derivative security
4 terms
Rule 10b5-1 plan regulatory
"exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
stock options financial
"This is an exercise of stock options and sale of the resulting shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transactions were reported for UTHR on this Form 4?
Paul A. Mahon, EVP & General Counsel of UTHR, exercised stock options for 8,300 shares at $146.03 per share and sold 8,300 common shares on August 20, 2026, in multiple open-market trades at prices around $520–$527 per share.
How many UNITED THERAPEUTICS (UTHR) options did Paul A. Mahon exercise and at what price?
Paul A. Mahon exercised 8,300 stock options for UNITED THERAPEUTICS common stock at an exercise price of $146.03 per share on August 20, 2026, converting them into 8,300 shares of common stock.
At what prices did Paul A. Mahon sell UTHR common stock?
He sold 8,300 shares of UNITED THERAPEUTICS common stock in multiple trades at prices ranging from approximately $519.33 to $527.21 per share, with several reported weighted average prices such as $520.03, $521.04, and $525.25 per share.
Was the UTHR insider trading activity done under a Rule 10b5-1 plan?
Yes. The options exercise and related sales were conducted under a pre-arranged Rule 10b5-1 trading plan that Paul A. Mahon entered into on August 11, 2025, as disclosed in the footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
